logo Hematology/Oncology Research Studies: Open for Enrollment Date: 05/27/20

Category: ONCOLOGY

Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)

NCT#/Phase: N/A
Phase 3
IRB#: 2019-091
Description: The Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT) directly addresses the need for the next generation of clinical trials for hepatic malignancies, incorporating rational reductions in therapy that ameliorate both short and long-term side effects for patients with good prognoses while simultaneously optimizing curative potential with intensification and new agent integration to improve outcomes for those with poor prognoses. This trial is the first international cooperative liver tumors trial in which a consensus approach was established by investigators representing Children’s Oncology Group (COG), Société Internationale d’Oncologie Pédiatrique – Epithelial Liver Tumor Study Group (SIOPEL) and the Japanese Children’s Cancer Group (JCCG). The study builds on treatment strategies established by the most recent trials from each of the individual consortia – COG (AHEP0731), SIOPEL (SIOPEL 3 and 4) and Japanese Pediatric Liver Tumor study group (JPLT2), but provides new approaches to all stages of HB and HCC patients keeping the aforementioned goals in focus. A critical aspect of this trial is the opportunity to correlate histologic and biologic heterogeneity with response and outcomes in all risk categories, providing promise for future refinement to the newly proposed risk stratification schema.
Inclusion:
Enrollment Status: Open for enrollment
Sponsor: Children's Oncology Group (COG)
Principal Investigator(s): Carla Golden, MD
Contact(s): Diane Olszewski (510-428-3885 x 3246)
COG CRA Office (510-428-3885 x8334)
Study Link: #

UCSF Benioff Children's Hospital Oakland • 747 52nd Street, Oakland, California 94609 &bull Phone: (510) 428-3000